相关实验视频
Updated: Jun 6, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.5K
评估BODE指数及其与慢性阻塞性肺病 (COPD) 患者的炎症媒介的关联
Kunjan Paresh Kumar Shah1, Himani Prashanth Bhat2, Mudra Kadam3
1Department of General Medicine, Dr. N.D. Desai Faculty and Medical Research Institute, Nadiad, IND.
Cureus
|November 25, 2024
概括
身体质量指数,气流阻塞,呼吸不全和运动能力 (BODE) 指数与慢性阻塞性肺病 (COPD) 中的炎症标志物相关. 这一发现对于改善COPD管理和患者的治疗结果至关重要.
科学领域:
- 肺部医学 肺部医学
- 临床研究 临床研究
- 生物标志物 生物标志物
背景情况:
- 慢性阻塞性肺病 (COPD) 显著影响日常生活,增加感染和心血管疾病的风险.
- 身体质量指数,气流阻塞,呼吸不全和运动能力 (BODE) 指数是评估COPD患者生存率的关键工具.
- 系统性炎症调解剂,包括细胞因子和化学因子,在COPD病变发生过程中发挥着关键作用.
研究的目的:
- 在稳定的COPD患者中调查BODE指数和全身炎症调解剂之间的关联.
- 确定炎症标志物是否可以作为通过BODE指数测量疾病严重程度的指标.
- 通过对BODE指数和炎症标志物的联合评估,探索COPD管理的潜在改进.
主要方法:
- 一项涉及85名临床稳定的COPD患者的横截面观察研究,使用GOLD标准诊断.
- 临床评估包括修改后的医学研究委员会 (MMRC) 呼吸障碍量表,COPD评估测试 (CAT) 和BODE指数.
- 用皮尔森分析测量和分析了血清中C反应性蛋白 (CRP),瘤亡因子-α (TNF-α) 和互白素-6 (IL-6) 的水平,以确定与BODE指数的相关性.
主要成果:
- BODE指数与GOLD阶段严重程度有显著的相关性 (p=0.001).
- 在较高的BODE指数阶段 (p=0.001) 观察到CRP,TNF-α和IL-6的升高水平.
- 在BODE指数和CRP (r=0.654),TNF-α (r=0.542) 和IL-6 (r=0.498) 之间发现了显著的正相关性.
结论:
- 在稳定的COPD患者中,BODE指数与系统性炎症标志物显著相关.
- 与BODE指数一起测量炎症标志物可以提供更全面的COPD严重性评估.
- 将BODE指数评估与系统性炎症标志物评估相结合,对于优化COPD管理和改善患者预后至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Management Using Bronchodilators and Corticosteroids
179
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
179
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K

